Aspirus UW Cancer Center is a clinical research site located in Wisconsin Rapids, Wisconsin, United States 54494.
Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Aspirus UW Cancer Center has participated in 37 clinical trials with 8 currently active.
Therapeutic areas: Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7.
Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology.
Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Aspirus UW Cancer Center has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Aspirus UW Cancer Center has 37 clinical trials on record, with 8 currently active. Their work covers Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7, Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7.
Aspirus UW Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.